1.37
Finanzdaten der Senti Biosciences Inc-Aktie (SNTI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
|
2.45%
16.80
|
16.40 | 16.17 | 15.21 | 13.36 |
Operating Income/Loss |
2.45%
-16.80
|
-16.40 | -16.17 | -15.21 | -13.36 |
Nonoperating Income/Loss |
9.63%
2.065
|
2.285 | 15.56 | -13.65 | 2.153 |
Income/Loss From Continuing Operations Before Tax |
4.40%
-14.73
|
-14.11 | -0.61 | -28.87 | -11.20 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
4.40%
-14.73
|
-14.11 | -0.61 | -28.87 | -11.20 |
|
4.40%
-14.73
|
-14.11 | -0.61 | -28.87 | -11.20 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | 2.522 | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
160.48%
26.08
|
10.01 | 0.0226 | 4.5771 | 4.572 |
Diluted Average Shares |
160.48%
26.08
|
10.01 | 0.0226 | 4.5771 | 4.572 |
Basic Earnings Per Share |
60.28%
-0.56
|
-1.41 | -0.62 | -6.31 | -2.45 |
Diluted Earnings Per Share |
60.28%
-0.56
|
-1.41 | -0.62 | -6.31 | -2.45 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | 2.522 | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):